These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34310033)

  • 1. The modified International Society of Urological Pathology system improves concordance between biopsy and prostatectomy tumour grade.
    Hennes DMZB; Sewell J; Kerger M; Hovens CM; Peters JS; Costello AJ; Ryan A; Corcoran NM
    BJU Int; 2021 Dec; 128 Suppl 3():45-51. PubMed ID: 34310033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling.
    Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G
    Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy.
    Nyk Ł; Tayara O; Ząbkowski T; Kryst P; Andrychowicz A; Malewski W
    BMC Urol; 2021 May; 21(1):82. PubMed ID: 34006281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.
    Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG
    BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
    Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
    BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of concordance of Gleason score between prostate biopsy and radical prostatectomy.
    Mansouri N; Msakni I; Gargouri F; Khiari R; Bouziani A; Laabidi B
    Tunis Med; 2018 Jul; 96(7):430-436. PubMed ID: 30430487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.
    Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM
    Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised Gleason grading system is a better predictor of indolent prostate cancer at the time of diagnosis: retrospective clinical-pathological study on matched biopsy and radical prostatectomy specimens.
    Giunchi F; Brunocilla E; Borghesi M; Rizzi S; Ricci MS; Romagnoli D; Martorana G; Schiavina R; Fiorentino M
    Clin Genitourin Cancer; 2014 Oct; 12(5):325-9. PubMed ID: 24583160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
    Preisser F; Würnschimmel C; Pose RM; Heinze A; Steuber T; Michl U; Salomon G; Mandel P; Graefen M; Tilki D
    Prostate; 2022 Feb; 82(2):254-259. PubMed ID: 34807461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?
    Van Praet C; Libbrecht L; D'Hondt F; Decaestecker K; Fonteyne V; Verschuere S; Rottey S; Praet M; De Visschere P; Lumen N;
    Clin Genitourin Cancer; 2014 Jun; 12(3):160-6. PubMed ID: 24361055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
    Epstein JI; Feng Z; Trock BJ; Pierorazio PM
    Eur Urol; 2012 May; 61(5):1019-24. PubMed ID: 22336380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
    Venkatesan AM; Mudairu-Dawodu E; Duran C; Stafford RJ; Yan Y; Wei W; Kundra V
    Cancer Imaging; 2021 Jan; 21(1):3. PubMed ID: 33407861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
    Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
    AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
    Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H
    BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we abstain from Gleason score 2-4 in the diagnosis of prostate cancer? Results of a German multicentre study.
    Brookman-May S; May M; Wieland WF; Lebentrau S; Gunia S; Koch S; Gilfrich C; Roigas J; Hoschke B; Burger M
    World J Urol; 2012 Feb; 30(1):97-103. PubMed ID: 21191597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy.
    Faraj SF; Bezerra SM; Yousefi K; Fedor H; Glavaris S; Han M; Partin AW; Humphreys E; Tosoian J; Johnson MH; Davicioni E; Trock BJ; Schaeffer EM; Ross AE; Netto GJ
    PLoS One; 2016; 11(1):e0146189. PubMed ID: 26731672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
    Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
    BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.